Commonly used chemotherapy drug can lead to heart failure: Study

IANS  |  London 

A drug, widely used for treatment of ovarian, bladder, lung, and stomach cancers, has the potential to cause heart toxicity that can lead to congestive heart failure, a study led by a of Indian origin, has found.

The drug also caused a wasting in the heart and the spleen.

The study, led by Ganesh Halade, Assistant at the University of in the US, found that disruption of the metabolism that controls immune responses in the spleen and heart is vital for heart maintenance, repair and control of

For the study, published in of Physiology -- Heart and Circulatory Physiology, the team used a mouse model to study the effect of doxorubicin on immunometabolism -- the study of how metabolism regulates immune cell function.

A dysregulated immunometabolism impairs resolution of inflammation, and chronic, non-resolving can lead to advanced

Halade's team found that doxorubicin is also involved in the deleterious response to the spleen.

First, doxorubicin was shown to induce irreversible dysregulation that lowered the levels of enzymes in the left ventricle of the heart, which in turn reduced the levels of bioactive lipids mediators produced by these enzymes, mediators that usually would help resolve

In the spleen, doxorubicin also poisoned a special group of marginal zone immune cells called CD169+ macrophages, causing the spleen to diminish in size.

It also caused an imbalance of the cell-signalling molecules called chemokines and cytokines, and this imbalance suggested suppressed defence capacity of spleen-leukocyte immune cells.

Specifically, the researchers found decreased levels of factor-in the spleen, and decreased levels of the immune-cells reparative marker MRC-1, also known as CD206, in the heart.

Thus, doxorubicin appears to have a splenocardiac impact in this non-model, Halade said.

--IANS

asj/rt/mag/bg

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, August 08 2018. 15:44 IST